1-[2-(4-Chlorobenzyloxy)-2-phenylethyl]-1H-benzotriazole

The asymmetric unit of the title compound, C21H18ClN3O, contains two crystallographically independent molecules which differ slightly in the orientations of chlorobenzyloxy units. In one of the molecules, the phenyl and chlorophenyl rings are oriented at dihedral angles of 38.09 (6) and 42.15 (6)°, respectively, with respect to the benzotriazole ring [43.23 (6) and 29.80 (6)° in the other molecule]. The dihedral angle between the phenyl and chlorophenyl rings is 77.63 (6)° in one of the molecules and 72.97 (6)° in the other. The crystal structure is stabilized by weak C—H⋯π interactions.

[1]  N. Blaton,et al.  The Crystal Structure of 1‐{2,4‐Dichloro‐β‐ [(2,4‐Dichloro‐Benzyl)Oxy] Phenethyl} Imidazole Hemihydrate: Miconazole. 1/2 H2O , 2010 .

[2]  Louis J. Farrugia,et al.  WinGX suite for small-molecule single-crystal crystallography , 1999 .

[3]  S. Yıldız,et al.  Synthesis and antimicrobial activity of some novel phenyl and benzimidazole substituted benzyl ethers. , 2007, Bioorganic & medicinal chemistry letters.

[4]  Tuncer Hökelek,et al.  1-[2-(2,6-Dichlorobenzyloxy)-2-(2-furyl)ethyl]-1H-benzimidazole , 2008, Acta crystallographica. Section E, Structure reports online.

[5]  S. Yıldız,et al.  Synthesis and antimicrobial activity of some novel furyl and benzimidazole substituted benzyl ethers , 2007 .

[6]  N. Blaton,et al.  cis-1-Acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1-imidazolylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine: ketoconazole. A crystal structure with disorder , 1979 .

[7]  J. Piekarczyk,et al.  Synthesis and activity of 1H-benzimidazole and 1H-benzotriazole derivatives as inhibitors of Acanthamoeba castellanii. , 2004, Bioorganic & medicinal chemistry.

[8]  Louis J. Farrugia,et al.  ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI) , 1997 .

[9]  Tuncer Hökelek,et al.  2-(1H-Benzotriazol-1-yl)-1-phenylethanol , 2010, Acta crystallographica. Section E, Structure reports online.

[10]  N. Blaton,et al.  cis-2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-1-piperazinyl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one (Itraconazole) , 1996 .

[11]  G. Sheldrick.  A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[12]  Anthony L. Spek,et al.  Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[13]  A. Freer,et al.  Structure of econazole , 1986 .

[14]  A. Katritzky,et al.  Regiospecific synthesis of 4-(2-oxoalkyl)pyridines. , 2001, Organic letters.

[15]  Basappa,et al.  Microwave-assisted synthesis of N-alkylated benzotriazole derivatives: antimicrobial studies. , 2006, Bioorganic & medicinal chemistry letters.

[16]  N. Meanwell,et al.  Fundamental structure-activity relationships associated with a new structural class of respiratory syncytial virus inhibitor. , 2003, Bioorganic & medicinal chemistry letters.

[17]  T. Hökelek,et al.  1-[2-(4-Bromobenzyloxy)-2-phenylethyl]-1H-1,2,4-triazole , 2008, Acta crystallographica. Section E, Structure reports online.

[18]  Tuncer Hökelek,et al.  1-[2-(4-Fluorobenzyloxy)-2-phenylethyl]-1H-benzimidazole , 2008, Acta crystallographica. Section E, Structure reports online.

[19]  Khouloud A. Alkhamis,et al.  Preparation and crystal characterization of a polymorph, a monohydrate, and an ethyl acetate solvate of the antifungal fluconazole. , 2004, Journal of pharmaceutical sciences.